PMID- 28148301 OWN - NLM STAT- MEDLINE DCOM- 20171211 LR - 20190731 IS - 1471-2474 (Electronic) IS - 1471-2474 (Linking) VI - 18 IP - 1 DP - 2017 Feb 2 TI - Protective effects of molecular hydrogen on steroid-induced osteonecrosis in rabbits via reducing oxidative stress and apoptosis. PG - 58 LID - 10.1186/s12891-017-1431-6 [doi] LID - 58 AB - BACKGROUND: The objective of this study was to investigate the protective effects of molecular hydrogen, a novel and selective antioxidant, on steroid-induced osteonecrosis (ON) in a rabbit model. METHODS: Sixty rabbits were randomly divided into two groups (model group and hydrogen group). Osteonecrosis was induced according to an established protocol of steroid-induced ON. Rabbits in the hydrogen group were treated with intraperitoneal injections of molecular hydrogen at 10 ml/kg body weight for seven consecutive days. Plasma levels of total cholesterol, triglycerides, soluble thrombomodulin(sTM), glutathione(GSH) and malondialdehyde(MDA) were measured before and after steroid administration. The presence or absence of ON was examined histopathologically. Oxidative injury and vascular injury were assessed in vivo by immunohistochemical staining of 8-hydoxy-2-deoxyguanosine(8-OHdG) and MDA, and ink artery infusion angiography. The terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) assays were performed to measure apoptosis. RESULTS: The incidence of steroid-induced ON was significantly lower in hydrogen group (28.6%) than that in model group (68.0%). No statistically differences were observed on the levels of total cholesterol and triglycerides. Oxidative injury, vascular injury and apoptosis were attenuated in the hydrogen group compared with those in the model group in vivo. CONCLUSIONS: These results suggested that molecular hydrogen prevents steroid-induced osteonecrosis in rabbits by suppressing oxidative injury, vascular injury and apoptosis. FAU - Li, Jia AU - Li J AD - Department of Orthopedics, The First Affiliated Hospital of Xi'an Jiaotong University, Yanta West Road, Xi'an, Shaanxi Province, 710061, People's Republic of China. happylee_xjtu@163.com. FAU - Ge, Zhaogang AU - Ge Z AD - Department of Joint Surgery, Honghui Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi Province, 710054, People's Republic of China. FAU - Fan, Lihong AU - Fan L AD - The first department of Orthopedics, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi Province, 710004, People's Republic of China. FAU - Wang, Kunzheng AU - Wang K AD - The first department of Orthopedics, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi Province, 710004, People's Republic of China. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20170202 PL - England TA - BMC Musculoskelet Disord JT - BMC musculoskeletal disorders JID - 100968565 RN - 0 (Antioxidants) RN - 0 (Glucocorticoids) RN - 0 (Thrombomodulin) RN - 0 (Triglycerides) RN - 4Y8F71G49Q (Malondialdehyde) RN - 7YNJ3PO35Z (Hydrogen) RN - 97C5T2UQ7J (Cholesterol) RN - GAN16C9B8O (Glutathione) RN - X4W7ZR7023 (Methylprednisolone) SB - IM MH - Angiography MH - Animals MH - Antioxidants/*pharmacology MH - Apoptosis/*drug effects MH - Cholesterol/blood MH - Disease Models, Animal MH - Glucocorticoids/*toxicity MH - Glutathione/blood MH - Humans MH - Hydrogen/*pharmacology MH - Immunohistochemistry MH - In Situ Nick-End Labeling MH - Incidence MH - Injections, Intraperitoneal MH - Male MH - Malondialdehyde/blood MH - Methylprednisolone/toxicity MH - Osteonecrosis/blood/chemically induced/epidemiology/*prevention & control MH - Oxidative Stress/*drug effects MH - Rabbits MH - Random Allocation MH - Thrombomodulin/blood MH - Triglycerides/blood PMC - PMC5288900 OTO - NOTNLM OT - Apoptosis OT - Molecular hydrogen OT - Osteonecrosis OT - Oxidative injury OT - Vascular injury EDAT- 2017/02/06 06:00 MHDA- 2017/12/12 06:00 PMCR- 2017/02/02 CRDT- 2017/02/03 06:00 PHST- 2016/06/09 00:00 [received] PHST- 2017/01/24 00:00 [accepted] PHST- 2017/02/03 06:00 [entrez] PHST- 2017/02/06 06:00 [pubmed] PHST- 2017/12/12 06:00 [medline] PHST- 2017/02/02 00:00 [pmc-release] AID - 10.1186/s12891-017-1431-6 [pii] AID - 1431 [pii] AID - 10.1186/s12891-017-1431-6 [doi] PST - epublish SO - BMC Musculoskelet Disord. 2017 Feb 2;18(1):58. doi: 10.1186/s12891-017-1431-6.